United Imaging Chairman: China's Medical AI Applications Rank Among Global Leaders

Deep News
昨天

At the 2026 Yabuli Forum Innovation Annual Meeting held in Shanghai on July 3rd and 4th, the theme of the event was "Innovation Drives, Intelligence Powers the Future—The 15th Five-Year Plan Blueprint and Corporate Opportunities."

During the Greater Health Forum, Xue Min, Chairman of United Imaging Group, commented on the current state of the medical industry in capital markets, noting its recent lackluster performance with significant capital outflows.

"However, I would like to take this opportunity to say that we should still have faith in the medical industry. It is a sector well worth deep cultivation, and its future holds great promise," he stated.

Discussing artificial intelligence, Xue highlighted that AI is driving transformation across countless industries, not just healthcare. All sectors are being impacted as AI reshapes entire industries. Medical equipment, processes, and systems are all experiencing the transformative impact of AI, which presents a significant opportunity.

He pointed out that China's development of medical AI has its own unique characteristics and possesses numerous favorable conditions. China's large population and vast number of medical institutions have resulted in the accumulation of massive amounts of medical data. Furthermore, the domestic medical system is relatively comprehensive, encompassing top-tier national hospitals, comprehensive hospitals, and various other institutions of different scales, from large to small and grassroots hospitals, each with distinct roles.

Additionally, China demonstrates strong capabilities in the practical implementation and application of AI within the medical field. On a global scale, China's medical AI applications are positioned within the top tier. "This is not about general large models, but rather scenario-specific, application-oriented models," he clarified.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10